News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Chenyu Lin: Exciting oncology opportunities at Duke Cancer Institute
Duke Cancer Institute/Youtube
Dec 7, 2024, 13:09

Chenyu Lin: Exciting oncology opportunities at Duke Cancer Institute

Chenyu Lin, Assistant Professor of Medicine at Duke University School of Medicine, shared on X:

“We are hiring MPNsm / MDS, MMsm oncologists at Duke Cancer Institute! Feel free to reach out if interested. Happy to meet and discuss at ASH24. Hybrid positions also available.”

Apply to the posted positions if interested.

ASH24 cancer cancer care Cancer Research Careers Chenyu Lin Duke Cancer Institute Hematology Oncology hybrid positions MDS MMSM MPNSM OncoDaily Oncology oncology careers Oncology Jobs
Special Coverage
Blog
Dec 7, 2024, 13:09
Chenyu Lin: Exciting oncology opportunities at Duke Cancer Institute
Career
Dec 7, 2024, 12:28
Honored to welcome Karen Knudsen to our board of directors - Exai Bio
Insight
Dec 7, 2024, 12:17
Art That Inspires Change - Richi Art Gallery
Blog
Dec 7, 2024, 11:45
Al-Ola A Abdallah: Celebrating mentees matching in Heme-Onc Fellowship
Blog
Dec 7, 2024, 11:26
Clement Fourny: Smart Labs had the privilege of hosting the 11th Catalysts cohort of Richi Entrepreneurs
Insight
Dec 7, 2024, 11:15
First hit on Autologous Stem Cell Transplantation in Mantle cell lymphoma
Blog
Dec 7, 2024, 11:11
Important factors associated with risk of developing melanoma in Rhode Island by Oliver Wisco
Blog
Dec 7, 2024, 11:11
Anirban Maitra: Comprehensive insights into KRAS signaling
Blog
Dec 7, 2024, 11:09
Matteo Lambertini: First ESMOYOC session at ESMO Asia 2024
Blog
Dec 7, 2024, 11:04
Lorenza Rimassa: Patient Advocate on Immunotherapy Choices in HCC and NSCLC at ESMO Asia 2024
Blog
Dec 7, 2024, 10:51
Vincenzo Corbo: MAPKhigh myCAF phenotype linked to immunotherapy resistance
Insight
Dec 7, 2024, 10:48
Use of the ESMO-Magnitude of Clinical Benefit Scale for HTA Recommendations